NorthView Acquisition Corp

CIK: 1859807•Ticker: NVAC

SPAC Overview

$180M

IPO Size

Failed

Current Status

2021

IPO Year

Timeline Progress

Investment Focus

Healthcare, Biopharmaceuticals

SPAC Team

Sponsors

NorthView Sponsor I

Leadership

Co-Founder, Director, Chief Executive Officer

Co-Founder, Director, Chief Financial Officer

Peter O’Rourke

Chairman of the Board, Independent Director

Independent Director

John J. Klobnak

Independent Director

Independent Director

Underwriters

I-Bankers Securities Dawson James Securities EarlyBirdCapital

Key Information

IPO Date

December 22, 2021

Completion Date

May 22, 2025

SPAC Ticker

NVAC

External Resources

View Detailed Analysis